Your session is about to expire
← Back to Search
Virtual Rehabilitation for Stroke (VAST-rehab Trial)
N/A
Waitlist Available
Led By Sean Savitz, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Occurrence of a hemorrhagic or ischemic stroke
Pre-stroke mRS less than 3
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, end of study (about 13-14 weeks after baseline)
Awards & highlights
VAST-rehab Trial Summary
This trial seeks to see if stroke patients can get rehab at home with virtual visits and education.
Who is the study for?
This trial is for individuals who have had a stroke and are recommended for rehabilitation. They must understand verbal commands, be able to use the internet, and have been relatively independent before their stroke (mRS less than 3). A CT or MRI must confirm their stroke. People with significant functional impairments from other diseases or conditions that could limit safe participation are not eligible.Check my eligibility
What is being tested?
The VAST-rehab study is testing a program where patients recovering from a stroke get virtual education and support to do rehabilitation exercises at home. It's checking if this online method can effectively engage patients in their recovery process.See study design
What are the potential side effects?
Since this trial involves telerehabilitation, there aren't typical medication side effects; however, participants may experience discomfort or fatigue related to physical therapy exercises. Technical issues with internet access might also affect the rehab process.
VAST-rehab Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had a stroke.
Select...
I was mostly independent before my stroke.
Select...
I can understand and follow verbal instructions.
VAST-rehab Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, end of study (about 13-14 weeks after baseline)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, end of study (about 13-14 weeks after baseline)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility as assessed by number of participants that completed all scheduled visits.
Secondary outcome measures
Change in Functional independence as assessed by the Functional Independence Measure (FIM)
Change in cognitive impairment as assessed by the Short Montreal Cognitive Assessment(s-MoCA)
Change in degree of disability or dependence as measured by the Modified Rankin Score(mRS)
+5 moreVAST-rehab Trial Design
1Treatment groups
Experimental Treatment
Group I: TelerehabilitationExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,977 Total Patients Enrolled
42 Trials studying Stroke
7,387 Patients Enrolled for Stroke
Sean Savitz, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
5 Previous Clinical Trials
310 Total Patients Enrolled
5 Trials studying Stroke
310 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your stroke must be confirmed by a CT scan or MRI.I can understand and follow verbal instructions.I do not have a severe illness that could shorten my life to under 6 months.I have a condition like Parkinson's or severe arthritis that significantly limits my daily activities.My doctor or therapist has recommended rehab activities for me.I was mostly independent before my stroke.I have had a stroke.
Research Study Groups:
This trial has the following groups:- Group 1: Telerehabilitation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there any availability for patient enrollment in this clinical trial?
"According to clinicaltrials.gov, this experiment is presently enlisting participants with the initiation date of April 20th 2020 and most recent update occurring on December 12th 2022."
Answered by AI
What is the current sample size for this clinical trial?
"Affirmative. Clinicaltrials.gov presents information that the trial, which was practically unveiled on April 20th 2020, is still actively seeking participants. A total of 30 individuals are required across a single medical centre to complete this study."
Answered by AI
Share this study with friends
Copy Link
Messenger